12th Annual Proteins & Antibodies Congress

24.-25. April 2019
London, UK

Teilnehmer: Dr. Meinolf Thiemann, Director Assay Development

Präsentation am 24. April 2019, 14:50 Uhr: "HERA-CD40L - A Novel Co-Stimulatory Agonist"

 

7th International Molecular Diagnostics Europe

6.-9. Mai 2019
Lissabon, Portugal

Teilnehmer: Dr. Ulrike Jägle, VP Regulatory Affairs

 

BIT's 12th Annual World Cancer Congress

15.-17. Mai 2019
Osaka, Japan

Teilnehmer: Dr. Christian Merz, Head of Cellular Analytics

Präsentation am 16. Mai 2019, 16:20 Uhr: "The tHERApeutic potential of HERA-CD40L in immunologic cancer treatment"

 

4th Annual Advances in Immuno-Oncology UK Congress

20.-21. Mai 2019
London, UK

Teilnehmer: Dr. Katharina Billian-Frey, Senior Scientist Drug Discovery/Protein Engineering

Präsentation am 21. Mai 2019, 14:30 Uhr: "HERA-CD40L: A Unique Hexavalent CD40 Agonist for Cancer Immunotherapy"

 

CIMT 2019 Annual Meeting

21.-23. Mai 2019
Mainz

Teilnehmer:
Dr. Niclas Kneisel, Alliance Manager
Dr. David Richards, Head of Immunology
Dr. Matthias Schröder, Senior Scientist Assay Development
Dr. Julian Sefrin, Senior Scientist Immunology

Präsentationen:

"HERA-CD40L, a hexavalent CD40 agonist, induces a significant T cell mediated anti-tumor immune response and shows superior activity in direct comparison to benchmark agonistic antibodies"
Poster-Präsentation: 22. Mai 2019, 15:30-18:00 Uhr; Vortrag: 23. Mai 2019, 10:30-11:45 Uhr ("Improving Immunity" session)
- David Richards

"The novel hexavalent human GITR agonist HERA-GITRL promotes anti-tumor efficacy independent of Fc-functionality and shows superior activity compared with the monoclonal anti-GITR antibody TRX518"
Poster-Präsentation: 22. Mai 2019, 15:30-18:00 Uhr ("Tumor Biology and Interaction with the Immune System" session)
- Matthias Schröder

"HERA-CD27L, a true CD27 agonist, has superior activity over benchmark agonistic antibodies and induces T cell activation for potent anti-tumor immunity"
Poster-Präsentation: 22. Mai 2019, 15:30-18:00 Uhr ("New Targets & New Leads" session)
- Julian Sefrin

 

2019 ASCO Annual Meeting

31. Mai - 4. Juni 2019
Chicago, IL, USA

Teilnehmer: Dr. Andriy Krendyukov, VP Medical Affairs